Get the Stockscreener App
47.11
2.95%
1.35
Azenta Inc stock is traded at $47.11, with a volume of 550.45K.
It is up +2.95% in the last 24 hours and up +15.27% over the past month.
Azenta Inc is a provider of life sciences solutions, enabling impactful breakthroughs and therapies to market faster. It provides a full suite of reliable cold-chain sample management solutions and genomic services across areas such as drug development, clinical research and advanced cell therapies for the industry's top pharmaceutical, biotech, academic and healthcare institutions globally. The company has two reportable segments that are Life Sciences Products and Life Sciences Services. It generates a substantial part of its revenue from its Life Sciences Services segment.
See More
Previous Close:
$45.76
Open:
$45.92
24h Volume:
550.45K
Relative Volume:
0.77
Market Cap:
$2.28B
Revenue:
$656.32M
Net Income/Loss:
$-164.17M
P/E Ratio:
-90.60
EPS:
-0.52
Net Cash Flow:
$40.93M
1W Performance:
+5.51%
1M Performance:
+15.27%
6M Performance:
-7.52%
1Y Performance:
-17.57%
1-Day Range:
$45.92
$47.49
1-Week Range:
$44.41
$47.49
52-Week Range:
$38.82
$69.16
Azenta Inc Stock (AZTA) Company Profile
Name
Azenta Inc
Sector
Industry
Phone
(978) 262-2400
Address
200 SUMMIT DRIVE, BURLINGTON
Compare AZTA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
AZTA
Azenta Inc
|
47.11 | 2.28B | 656.32M | -164.17M | 40.93M | -0.52 |
|
ISRG
Intuitive Surgical Inc
|
538.55 | 192.83B | 7.87B | 2.24B | 586.00M | 4.25 |
|
BDX
Becton Dickinson Co
|
221.98 | 64.77B | 20.18B | 1.73B | 3.07B | 5.51 |
|
ALC
Alcon Inc
|
88.23 | 43.75B | 9.76B | 1.16B | 665.00M | 0.72 |
|
RMD
Resmed Inc
|
249.33 | 36.84B | 4.81B | 1.11B | 1.35B | 6.16 |
|
WST
West Pharmaceutical Services Inc
|
323.32 | 23.33B | 2.88B | 499.60M | 321.60M | 7.41 |
Azenta Inc Stock (AZTA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-04-24 | Initiated | Jefferies | Hold |
| Feb-01-24 | Reiterated | B. Riley Securities | Buy |
| Jul-19-23 | Initiated | Raymond James | Mkt Perform |
| May-10-23 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Feb-09-23 | Downgrade | Stephens | Overweight → Equal-Weight |
| Jan-03-23 | Downgrade | Evercore ISI | Outperform → In-line |
| Mar-31-22 | Resumed | B. Riley Securities | Buy |
| Mar-21-22 | Initiated | Evercore ISI | Outperform |
View All
Azenta Inc Stock (AZTA) Latest News
Azenta Inc. (AZTA) reports earnings - Quartzy
Azenta (FRA:BA3) Debt-to-EBITDA : 1.79 (As of Jun. 2024) - GuruFocus.com
Azenta's SVP sells shares worth $45,639 By Investing.com - Investing.com Canada
Azenta's CFO Herman Cueto sells $28,529 in stock - Investing.com India
B. Metzler seel. Sohn & Co. Holding AG Takes Position in Azenta, Inc. (NASDAQ:AZTA) - MarketBeat
Azenta SVP Wang sells $13,944 in stock By Investing.com - Investing.com Nigeria
Azenta SVP Wang sells $13,944 in stock - Investing.com India
Azenta's SVP sells shares worth $45,639 - Investing.com
Azenta's CFO Herman Cueto sells $28,529 in stock By Investing.com - Investing.com Australia
Azenta's SVP and CHRO Olga Pirogova sells shares worth $21,958 By Investing.com - Investing.com Australia
Azenta's SVP and CHRO Olga Pirogova sells shares worth $21,958 - Investing.com
Azenta to Participate in Stephens Annual Investment Conference - GuruFocus.com
Azenta, Inc. (NASDAQ:AZTA) Shares Sold by Ontario Teachers Pension Plan Board - MarketBeat
Principal Financial Group Inc. Sells 67,809 Shares of Azenta, Inc. (NASDAQ:AZTA) - MarketBeat
Premier Fund Managers Ltd Makes New Investment in Azenta, Inc. (NASDAQ:AZTA) - MarketBeat
Director Didier Hirsch Acquires Additional Shares of Azenta Inc (AZTA) - GuruFocus.com
Natixis Advisors LLC Sells 18,668 Shares of Azenta, Inc. (NASDAQ:AZTA) - MarketBeat
Flex Set to Join S&P MidCap 400; Azenta and Concentra Group Holdings to Join S&P SmallCap 600 - Yahoo Finance
Azenta director Martin Madaus purchases $201,403 in company stock - Investing.com
Azenta director Martin Madaus purchases $201,403 in company stock By Investing.com - Investing.com UK
Azenta Obtains Regulatory Approval for Clinical Long-Read Whole Genome Sequencing Test - Technology Networks
Azenta (NASDAQ:AZTA) Sets New 1-Year LowWhat's Next? - MarketBeat
Azenta, Inc. (NASDAQ:AZTA) Sees Significant Drop in Short Interest - MarketBeat
Analysts Have Just Cut Their Azenta, Inc. (NASDAQ:AZTA) Revenue Estimates By 14% - Simply Wall St
Azenta, Inc. (NASDAQ:AZTA) Analysts Just Slashed This Year's Revenue Estimates By 14% - Yahoo Finance
Azenta, Inc. (NASDAQ:AZTA) Analysts Are Cutting Their Estimates: Here's What You Need To Know - Yahoo Finance
Royce & Associates LP Increases Position in Azenta, Inc. (NASDAQ:AZTA) - MarketBeat
Azenta Inc (AZTA) Trading Down 3.84% on Nov 14 - GuruFocus.com
Azenta to Participate in Stephens Annual Investment Conference – Company Announcement - Financial Times
Azenta shares target trimmed by Evercore ISI amid challenging macro - Investing.com India
Azenta Full Year 2024 Earnings: EPS Misses Expectations - Yahoo Finance
Shareholders Should Be Pleased With Azenta, Inc.'s (NASDAQ:AZTA) Price - Simply Wall St
Finansavisen - Finansavisen
Kayne Anderson Rudnick Investment Management LLC's Strategic Red - GuruFocus.com
Biobanking Market to Reach Market Valuation of USD 95.5 Billion by 2031 | SkyQuest Technology - GlobeNewswire Inc.
Azenta (NASDAQ:AZTA) Posts Earnings Results, Beats Expectations By $0.08 EPS - MarketBeat
Azenta (NASDAQ:AZTA) Given New $55.00 Price Target at Needham & Company LLC - MarketBeat
Azenta, Inc. (NASDAQ:AZTA) Q4 2024 Earnings Call Transcript - Insider Monkey
Earnings call: Azenta reports mixed FY 2024 results, plans B Medical sale - Investing.com UK
Azenta Inc (AZTA) Q4 2024 Earnings Call Highlights: Navigating M - GuruFocus.com
Azenta reports modest growth and portfolio streamlining By Investing.com - Investing.com Australia
Azenta (AZTA) Q4 Earnings Top Estimates - MSN
Azenta Inc (AZTA) Q4 2024 Earnings Call Highlights: Navigating Market Challenges with Strategic ... - Yahoo Finance
Azenta, Inc. Reveals Strategic Portfolio Streamlining - TipRanks
Azenta, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended September 30, 2024 - Marketscreener.com
Azenta Appoints New CFO Amid Revenue Growth - TipRanks
Azenta Inc (AZTA) Q4 2024 Earnings: Revenue at $170M Beats Estimates, Reports GAAP EPS Loss of $0.10 - GuruFocus.com
Brooks: Fiscal Q4 Earnings Snapshot - Marketscreener.com
Azenta reports modest growth and portfolio streamlining - Investing.com India
Azenta Reports Fourth Quarter and Full Year Fiscal 2024 Results; Announces the Plan to Sell B Medical Systems and Appoints Lawrence Y. Lin as CFO - PR Newswire
WCM Investment Management LLC Cuts Stock Holdings in Azenta, Inc. (NASDAQ:AZTA) - MarketBeat
Azenta Inc Stock (AZTA) Financials Data
Revenue
Net Income
Cash Flow
EPS
Azenta Inc Stock (AZTA) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Hughes Violetta | VP, Chief Accounting Officer |
Nov 19 '24 |
Sale |
40.07 |
163 |
6,531 |
9,920 |
| Zhou Ginger | SVP and General Manager, Genom |
Nov 19 '24 |
Sale |
40.07 |
491 |
19,674 |
27,499 |
| Wang David Dong | SVP & GM, SMS |
Nov 19 '24 |
Sale |
40.07 |
348 |
13,944 |
24,114 |
| Joseph Jason | SVP, General Counsel, Secy. |
Nov 19 '24 |
Sale |
40.07 |
1,139 |
45,640 |
112,564 |
| Cueto Herman | EVP, Chief Financial Officer |
Nov 19 '24 |
Sale |
40.07 |
712 |
28,530 |
23,892 |
| Marotta John | President and CEO |
Nov 18 '24 |
Buy |
39.48 |
12,717 |
502,066 |
99,612 |
| Marotta John | President and CEO |
Nov 19 '24 |
Buy |
40.67 |
1,250 |
50,838 |
100,862 |
| Cornog William L | Director |
Nov 18 '24 |
Buy |
39.60 |
12,500 |
495,000 |
14,755 |
| HIRSCH DIDIER | Director |
Nov 18 '24 |
Buy |
39.50 |
1,000 |
39,500 |
3,465 |
| Madaus Martin D | Director |
Nov 19 '24 |
Buy |
40.77 |
4,940 |
201,404 |
7,405 |
0.14%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):